Pancreatic stellate cells reduce insulin expression and induce apoptosis in pancreatic β-cells

Biochemical and Biophysical Research Communications

Volumn 433, Issue 3, 2013, Pages 292-297

  Kikuta, Kazuhiro ^a   Masamune, Atsushi ^a   Hamada, Shin ^a   Takikawa, Tetsuya ^a   Nakano, Eriko ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes; Islet fibrosis; Myofibroblast; Pancreatic cancer; Pancreatitis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE; INSULIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; COCULTURE; CONTROLLED STUDY; DEPOLARIZATION; DIABETES MELLITUS; ENZYME ACTIVATION; MITOCHONDRION; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREATIC STELLATE CELL; PHENOTYPE; PRIORITY JOURNAL; RAT;

ACTINS; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CASPASES; CELL SURVIVAL; COCULTURE TECHNIQUES; FIBROSIS; GENE EXPRESSION; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; ONIUM COMPOUNDS; PANCREATIC STELLATE CELLS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84876313494     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.095     Document Type: Article

References (36)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34:S62-S69.
2. Ewald N., Kaufmann C., Raspe A., et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab. Res. Rev. 2012, 28:338-342.
3. Chen N., Unnikrishnan I.R., Anjana R.M., et al. The complex exocrine-endocrine relationship and secondary diabetes in exocrine pancreatic disorders. J. Clin. Gastroenterol. 2011, 45:850-861.
4. Sasikala M., Talukdar R., Pavan kumar P., et al. β-Cell dysfunction in chronic pancreatitis. Dig. Dis. Sci. 2012, 57:1764-1772.
5. Schrader H., Menge B.A., Schneider S., et al. Reduced pancreatic volume and β-cell area in patients with chronic pancreatitis. Gastroenterology 2009, 136:513-522.
6. Butler A.E., Janson J., Bonner-Weir S., et al. β-Cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
7. Kim J.W., Ko S.H., Cho J.H., et al. Loss of β-cells with fibrotic islet destruction in type 2 diabetes mellitus. Front. Biosci. 2008, 13:6022-6033.
8. Pick A., Clark J., Kubstrup C., et al. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 1998, 47:358-364.
9. Homo-Delarche F., Calderari S., Irminger J.C., et al. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes 2006, 55:1625-1633.
10. Tikellis C., Wookey P.J., Candido R., et al. Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. Diabetes 2004, 53:989-997.
11. Apte M.V., Haber P.S., Applegate T.L., et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation and culture. Gut 1998, 43:128-133.
12. Bachem M.G., Schneider E., Gross H., et al. Identification, culture, and characterization of pancreas stellate cells in rats and humans. Gastroenterology 1998, 115:421-432.
13. Masamune A., Shimosegawa T. Signal transduction in pancreatic stellate cells. J. Gastroenterol. 2009, 44:249-260.
14. Masamune A., Watanabe T., Kikuta K., et al. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin. Gastroenterol. Hepatol. 2009, 7:S48-S54.
15. Erkan M., Adler G., Apte M.V., et al. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut 2012, 61:172-178.
16. Chick W.L., Warren S., Chute R.N., et al. A transplantable insulinoma in the rat. Proc. Natl. Acad. Sci. USA 1977, 74:628-632.
17. Masamune A., Satoh M., Kikuta K., et al. Differential roles of signaling pathways for proliferation and migration of rat pancreatic stellate cells. Tohoku J. Exp. Med. 2003, 199:69-84.
18. Masamune A., Watanabe T., Kikuta K., et al. Nuclear expression of interleukin-33 in pancreatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G821-G832.
19. Dolber P.C., Spach M.S. Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J. Histochem. Cytochem. 1993, 41:465-469.
20. Zhang D., Fujii I., Lin C., et al. The stimulatory activities of polysaccharide compounds derived from Algae extracts on insulin secretion in vitro. Biol. Pharm. Bull. 2008, 31:921-924.
21. Kikuta K., Masamune A., Watanabe T., et al. Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2010, 403:380-384.
22. Smiley S.T., Reers M., Mottola-Hartshorn C., et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA 1991, 88:3671-3675.
23. Kono H., Rusyn I., Uesugi T., et al. Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G1005-G1012.
24. Masamune A., Kikuta K., Watanabe T., et al. Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G709-G717.
25. Hwang R.F., Moore T., Arumugam T., et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008, 68:918-926.
26. Mantoni T.S., Lunardi S., Al-Assar O., et al. Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling. Cancer Res. 2011, 71:3453-3458.
27. Liadis N., Murakami K., Eweida M., et al. Caspase-3-dependent β-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol. Cell. Biol. 2005, 25:3620-3629.
28. Radziszewska A., Schroer S.A., Choi D., et al. Absence of caspase-3 protects pancreatic β-cells from c-Myc-induced apoptosis without leading to tumor formation. J. Biol. Chem. 2009, 284:10947-10956.
29. Wolf G., Aumann N., Michalska M., et al. Peroxiredoxin III protects pancreatic ß cells from apoptosis. J. Endocrinol. 2010, 207:163-175.
30. Kim K.A., Lee M.S. Recent progress in research on β-cell apoptosis by cytokines. Front. Biosci. 2009, 14:657-664.
31. Chan J.Y., Cooney G.J., Biden T.J., et al. Differential regulation of adaptive and apoptotic unfolded protein response signalling by cytokine-induced nitric oxide production in mouse pancreatic β cells. Diabetologia 2011, 54:1766-1776.
32. Masamune A., Watanabe T., Kikuta K., et al. NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G99-G108.
33. Ohashi K., Kim J.H., Hara H., et al. WBN/Kob rats. A new spontaneously occurring model of chronic pancreatitis. Int. J. Pancreatol. 1990, 6:231-247.
34. Diani A.R., Sawada G., Wyse B., et al. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E116-E122.
35. Ko S.H., Kwon H.S., Kim S.R., et al. Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats. Biochem. Biophys. Res. Commun. 2004, 316:114-122.
36. Lee E., Ryu G.R., Ko S.H., et al. Antioxidant treatment may protect pancreatic beta cells through the attenuation of islet fibrosis in an animal model of type 2 diabetes. Biochem. Biophys. Res. Commun. 2011, 414:397-402.